Vivet Therapeutics - innovative gene therapy treatments for orphan diseases

innovative gene therapy treatments for orphan diseases

About us
Pipeline
Investors
News
Events
Patients & Families
Work at Vivet

News

Vivet Therapeutics → News

News

Author By admin_viv3tPosted on 2 April 201731 May 2022

FDA news : Cellular & Gene Therapy Guidances

A useful resource of Cellular & Gene Therapy Guidance Documents

Author By admin_viv3tPosted on 1 April 201731 May 2022

Vivet Therapeutics raises €37.5 million in Series A financing round

Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases

Previous page 1 2 3

About us

Our DNA
Board members
Our leadership
Partners

Pipeline

VTX-801 – Wilson’s disease
> VTX-801 in Wilson disease – GATEWAY
VTX-802 & VTX-803 – PFIC
VTX-804 – Citrullinemia Type 1

Patients & Families

Patient advocacy
Patient & Families ressources
Compassionate Use and Expanded Access

News
Events
Investors
Work at Vivet
Contact